Scarica l'app Stockscreener
10.75
1.47%
0.14
Precedente Chiudi:
$10.61
Aprire:
$10.61
Volume 24 ore:
43,249
Relative Volume:
0.37
Capitalizzazione di mercato:
$67.49M
Reddito:
-
Utile/perdita netta:
$-14.56M
Rapporto P/E:
-0.6391
EPS:
-16.82
Flusso di cassa netto:
$-12.46M
1 W Prestazione:
+9.30%
1M Prestazione:
+51.63%
6M Prestazione:
+76.20%
1 anno Prestazione:
+84.35%
Intervallo 1D:
$10.40
$10.95
Intervallo di 1 settimana:
$9.40
$11.00
Portata 52W:
$4.63
$11.00
Tenax Therapeutics Inc Stock (TENX) Company Profile
Nome
Tenax Therapeutics Inc
Settore
Industria
Telefono
919-855-2100
Indirizzo
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Confronta TENX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TENX
Tenax Therapeutics Inc
|
10.81 | 66.24M | 0 | -14.56M | -12.46M | -16.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.52 | 115.62B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
738.23 | 79.10B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
853.38 | 52.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.84 | 51.72B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
200.71 | 42.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-08 | Iniziato | Piper Sandler | Overweight |
| 2024-10-24 | Iniziato | Leerink Partners | Outperform |
| 2024-10-14 | Iniziato | Guggenheim | Buy |
| 2024-09-30 | Iniziato | William Blair | Outperform |
| 2017-05-18 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2014-12-16 | Iniziato | MLV & Co | Buy |
| 2014-11-18 | Iniziato | WallachBeth | Buy |
Mostra tutto
Tenax Therapeutics Inc Borsa (TENX) Ultime notizie
Discipline and Rules-Based Execution in TENX Response - news.stocktradersdaily.com
What analysts say about Tenax Therapeutics Inc stockCovered Call Writing & Build Winning Strategies With Zero Cost - earlytimes.in
JANUS HENDERSON GROUP PLC Acquires Additional Shares in Tenax Therapeutics Inc - GuruFocus
Tenax Therapeutics (NASDAQ:TENX) Insider Stuart Rich Buys 2,500 Shares - MarketBeat
Tenax Therapeutics director Rich Stuart buys $50,792 in stock By Investing.com - Investing.com South Africa
Tenax Therapeutics director Rich Stuart buys $50,792 in stock - Investing.com
Officer/Dir Rich Buys 5,000 ($50.8K) Of Tenax Therapeutics Inc [TENX] - TradingView — Track All Markets
TENAX Therapeutics CMO Stuart Rich Acquires 5,000 Shares - TradingView — Track All Markets
Tenax Therapeutics (NASDAQ:TENX) Insider Stuart Rich Buys 1,500 Shares - MarketBeat
Officer/Dir Rich Buys 5,000 ($45.6K) Of Tenax Therapeutics Inc [TENX] - TradingView
Tenax Therapeutics Inc. (TENX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What technical signals suggest for Tenax Therapeutics Inc. stock2025 Macro Impact & Short-Term High Return Strategies - Newser
Behavioral Patterns of TENX and Institutional Flows - news.stocktradersdaily.com
Why Tenax Therapeutics Inc. stock could benefit from AI revolution2025 Trading Volume Trends & Comprehensive Market Scan Insights - Newser
Financial Analysis: Mainz Biomed (NASDAQ:MYNZ) vs. Tenax Therapeutics (NASDAQ:TENX) - Defense World
Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
What analysts say about Tenax Therapeutics Inc. stockMean Reversion Trades & Market-Leading Growth Rates - earlytimes.in
Tenax Therapeutics to Participate in Upcoming Investor Conferences - Investing News Network
Tenax Therapeutics (Nasdaq: TENX) plans Dec. 2 and 4 fireside chats at Evercore, Piper - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
(TENX) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
GIORDANO CHRISTOPHER THOMAS Insider Trades - Nasdaq
Is Tenax Therapeutics Inc. stock a safe buy before earningsEarnings Growth Report & Reliable Volume Spike Trade Alerts - newser.com
Giordano buys Tenax Therapeutics (TENX) shares worth $19,999 By Investing.com - Investing.com Nigeria
Insider Buying: Christopher Giordano Acquires Shares of Tenax Therapeutics Inc (TENX) - GuruFocus
Giordano buys Tenax Therapeutics (TENX) shares worth $19,999 - Investing.com
CEO Giordano Buys 2,605 ($20K) Of Tenax Therapeutics Inc [TENX] - TradingView
[Form 4] TENAX THERAPEUTICS, INC. Insider Trading Activity - Stock Titan
Tenax Therapeutics interim CFO McGauley buys shares worth $58,164 By Investing.com - Investing.com Nigeria
Insider Buying: June Almenoff Acquires Shares of Tenax Therapeutics Inc (TENX) - GuruFocus
Tenax Therapeutics interim CFO McGauley buys shares worth $58,164 - Investing.com
Understanding Tenax Therapeutics Inc.’s price movementProfit Target & Fast Moving Trade Plans - newser.com
TENAX Therapeutics Executives Increase Their Holdings - TradingView
Almenoff June Sherie, director at Tenax Therapeutics, buys $14944 in shares - Investing.com Canada
CFO McGauley Buys 8,000 ($58.2K) Of Tenax Therapeutics Inc [TENX] - TradingView
TENAX Therapeutics Director June Sherie Almenoff Acquires 1,993 Shares - TradingView
Can machine learning forecast Tenax Therapeutics Inc. recovery2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com
Why Tenax Therapeutics Inc. stock is a must watch in 20252025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com
How sentiment analysis helps forecast Tenax Therapeutics Inc.2025 EndofYear Setup & High Conviction Trade Alerts - newser.com
Historical volatility pattern of Tenax Therapeutics Inc. visualizedPortfolio Value Summary & Accurate Trade Setup Notifications - newser.com
Tenax Therapeutics reports Q3 EPS (40c), consensus ($1.12) - MSN
Forecasting Tenax Therapeutics Inc. price range with options dataWeekly Trade Report & Risk Controlled Swing Alerts - newser.com
Tenax Therapeutics Inc Azioni (TENX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tenax Therapeutics Inc Azioni (TENX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Rich Stuart | Chief Medical Officer |
Dec 08 '25 |
Buy |
10.10 |
2,500 |
25,250 |
5,000 |
| Rich Stuart | Chief Medical Officer |
Dec 04 '25 |
Buy |
9.20 |
2,500 |
22,998 |
2,500 |
| Rich Stuart | Chief Medical Officer |
Dec 03 '25 |
Buy |
9.08 |
1,500 |
13,618 |
2,766 |
| Rich Stuart | Chief Medical Officer |
Dec 02 '25 |
Buy |
9.01 |
1,000 |
9,006 |
1,266 |
| Giordano Christopher Thomas | CEO |
Nov 18 '25 |
Buy |
7.75 |
1,612 |
12,500 |
1,612 |
| Giordano Christopher Thomas | CEO |
Nov 20 '25 |
Buy |
7.59 |
538 |
4,083 |
2,605 |
| Giordano Christopher Thomas | CEO |
Nov 19 '25 |
Buy |
7.51 |
455 |
3,417 |
2,067 |
| MCGAULEY THOMAS | Interim CFO |
Nov 17 '25 |
Buy |
7.25 |
6,000 |
43,490 |
5,000 |
| MCGAULEY THOMAS | Interim CFO |
Nov 17 '25 |
Buy |
7.34 |
2,000 |
14,674 |
2,000 |
| Almenoff June Sherie | Director |
Nov 18 '25 |
Buy |
7.52 |
1,900 |
14,280 |
1,993 |
0.42%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):